127 related articles for article (PubMed ID: 33188646)
1. The role of osteopontin in oral cancer: A brief review with emphasis on clinical applications.
Dos Santos ES; Ramos JC; Roza ALOC; Mariz BALA; Paes Leme AF
Oral Dis; 2022 Mar; 28(2):326-335. PubMed ID: 33188646
[TBL] [Abstract][Full Text] [Related]
2. Silencing Osteopontin Expression Inhibits Proliferation, Invasion and Induce Altered Protein Expression in Melanoma Cells.
Kiss T; Jámbor K; Koroknai V; Szász I; Bárdos H; Mokánszki A; Ádány R; Balázs M
Pathol Oncol Res; 2021; 27():581395. PubMed ID: 34257527
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin expression in co-cultures of human squamous cell carcinoma-derived cells and osteoblastic cells and its effects on the neoplastic cell phenotype and osteoclastic activation.
Teixeira LN; de Castro Raucci LM; Alonso GC; Coletta RD; Rosa AL; de Oliveira PT
Tumour Biol; 2016 Sep; 37(9):12371-12385. PubMed ID: 27312487
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of ethanol extract of Ocimum sanctum on osteopontin mediated metastasis of NCI-H460 non-small cell lung cancer cells.
Kwak TK; Sohn EJ; Kim S; Won G; Choi JU; Jeong K; Jeong M; Kwon OS; Kim SH
BMC Complement Altern Med; 2014 Oct; 14():419. PubMed ID: 25345853
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin knockdown inhibits αv,β3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/mTOR pathway.
Zhang H; Guo M; Chen JH; Wang Z; Du XF; Liu PX; Li WH
Cell Physiol Biochem; 2014; 33(4):991-1002. PubMed ID: 24714122
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of osteopontin induces angiogenesis of endothelial progenitor cells via the avβ3/PI3K/AKT/eNOS/NO signaling pathway in glioma cells.
Wang Y; Yan W; Lu X; Qian C; Zhang J; Li P; Shi L; Zhao P; Fu Z; Pu P; Kang C; Jiang T; Liu N; You Y
Eur J Cell Biol; 2011 Aug; 90(8):642-8. PubMed ID: 21616556
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin increases lung cancer cells migration via activation of the alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathway.
Fong YC; Liu SC; Huang CY; Li TM; Hsu SF; Kao ST; Tsai FJ; Chen WC; Chen CY; Tang CH
Lung Cancer; 2009 Jun; 64(3):263-70. PubMed ID: 18996613
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
[TBL] [Abstract][Full Text] [Related]
9. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
[TBL] [Abstract][Full Text] [Related]
10. In vitro and clinical data analysis of Osteopontin as a prognostic indicator in colorectal cancer.
Wei R; Wong JPC; Lyu P; Xi X; Tong O; Zhang SD; Yuen HF; Shirasawa S; Kwok HF
J Cell Mol Med; 2018 Sep; 22(9):4097-4105. PubMed ID: 29851214
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of hepatitis C virus (HCV)-induced osteopontin and its role in epithelial to mesenchymal transition of hepatocytes.
Iqbal J; McRae S; Banaudha K; Mai T; Waris G
J Biol Chem; 2013 Dec; 288(52):36994-7009. PubMed ID: 24240095
[TBL] [Abstract][Full Text] [Related]
12. Cloning of hamster osteopontin and expression distribution in normal tissues and experimentally induced oral squamous-cell carcinoma.
Jin H; Valverde P; Chen J
Arch Oral Biol; 2006 Mar; 51(3):236-45. PubMed ID: 16095557
[TBL] [Abstract][Full Text] [Related]
13. MALAT1/miR-127-5p Regulates Osteopontin (OPN)-Mediated Proliferation of Human Chondrocytes Through PI3K/Akt Pathway.
Liang J; Xu L; Zhou F; Liu AM; Ge HX; Chen YY; Tu M
J Cell Biochem; 2018 Jan; 119(1):431-439. PubMed ID: 28590075
[TBL] [Abstract][Full Text] [Related]
14. The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis.
Chiu YW; Tu HF; Wang IK; Wu CH; Chang KW; Liu TY; Kao SY
Oral Oncol; 2010 Apr; 46(4):302-6. PubMed ID: 20219412
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin enhances the expression of HOTAIR in cancer cells via IRF1.
Yang G; Zhang S; Gao F; Liu Z; Lu M; Peng S; Zhang T; Zhang F
Biochim Biophys Acta; 2014 Sep; 1839(9):837-48. PubMed ID: 24999034
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin Promotes Invasion, Migration and Epithelial-Mesenchymal Transition of Human Endometrial Carcinoma Cell HEC-1A Through AKT and ERK1/2 Signaling.
Li Y; Xie Y; Cui D; Ma Y; Sui L; Zhu C; Kong H; Kong Y
Cell Physiol Biochem; 2015; 37(4):1503-12. PubMed ID: 26509489
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells.
Das R; Mahabeleshwar GH; Kundu GC
J Biol Chem; 2003 Aug; 278(31):28593-606. PubMed ID: 12771144
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin-c splicing isoform contributes to ovarian cancer progression.
Tilli TM; Franco VF; Robbs BK; Wanderley JL; da Silva FR; de Mello KD; Viola JP; Weber GF; Gimba ER
Mol Cancer Res; 2011 Mar; 9(3):280-93. PubMed ID: 21263033
[TBL] [Abstract][Full Text] [Related]
19. The bovine Lactoferrin-Osteopontin complex increases proliferation of human intestinal epithelial cells by activating the PI3K/Akt signaling pathway.
Liu L; Jiang R; Liu J; Lönnerdal B
Food Chem; 2020 Apr; 310():125919. PubMed ID: 31841940
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of osteopontin promotes resistance to cisplatin treatment in HCC.
Ding K; Fan L; Chen S; Wang Y; Yu H; Sun Y; Yu J; Wang L; Liu X; Liu Y
Oncol Rep; 2015 Dec; 34(6):3297-303. PubMed ID: 26397192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]